Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy
暂无分享,去创建一个
T. Kanda | M. Fujimoto | T. Kanekura | T. Hashimoto | T. Matsushita | Y. Tanino | A. Nishino | T. Koga | K. Kawai | M. Kuwana | M. Hasegawa | K. Takehara | Y. Hamaguchi | R. Aoki | Y. Inokoshi | A. Igarashi | N. Ishiguro | R. Sogame | T. Abe | K. Kaji | N. Ando | N. Sugimoto | Y. Ichimura | Maria Habuchi | Yayoi Inokoshi
[1] M. Fujimoto,et al. Myositis-specific anti-155/140 autoantibodies target transcription intermediary factor 1 family proteins. , 2012, Arthritis and rheumatism.
[2] I. Lundberg,et al. Pathogenesis, classification and treatment of inflammatory myopathies , 2011, Nature Reviews Rheumatology.
[3] M. Fujimoto,et al. Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study. , 2011, Archives of dermatology.
[4] L. Christopher‐Stine. Clinical and serologic characterization of an Argentine pediatric myositis cohort: identification of a novel autoantibody (anti-MJ) to a 142-kDa protein , 2010 .
[5] J. Vencovský,et al. Clinical Associations Of Anti-p140 Autoantibodies In Adult Myositis , 2010 .
[6] M. Barton,et al. Regulation of p53: TRIM24 enters the RING , 2009, Cell cycle.
[7] E. Taraldsrud,et al. [Myositis-specific autoantibodies]. , 2009, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.
[8] T. Fujita,et al. RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease. , 2009, Arthritis and rheumatism.
[9] N. McHugh,et al. Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression. , 2009, Rheumatology.
[10] L. Wedderburn,et al. Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis , 2009, Arthritis and rheumatism.
[11] L. Wedderburn,et al. Clinical associations of autoantibodies to a p155/140 kDa doublet protein in juvenile dermatomyositis. , 2007, Rheumatology.
[12] A. Zinn,et al. Dynamic regulation of p53 subnuclear localization and senescence by MORC3. , 2007, Molecular biology of the cell.
[13] W. Ollier,et al. The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis , 2007, Annals of the rheumatic diseases.
[14] THE CLINICAL ASSOCIATIONS , 2007 .
[15] M. Fujimoto,et al. Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy. , 2007, Rheumatology.
[16] I. Targoff,et al. A novel autoantibody to a 155-kd protein is associated with dermatomyositis. , 2006, Arthritis and rheumatism.
[17] R. Sontheimer. Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis siné myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? , 2002, Journal of the American Academy of Dermatology.
[18] C. Oddis,et al. Clinical and serological characterization of the anti-MJ antibody in childhood myositis , 1997 .
[19] A. Bohan,et al. Polymyositis and dermatomyositis (second of two parts). , 1975, The New England journal of medicine.
[20] A. Bohan,et al. Polymyositis and dermatomyositis (second of two parts). , 1975 .